DIANA PENCHEVA: Open Payments
NPI 1023353265 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,497 in 68 payments from 16 companies in 2025. Trend: 2023 $628 · 2024 $482 · 2025 $1,497
Food & beverage: $1,402Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $293 |
| Janssen Biotech, Inc. | 8 | $265 |
| Novartis Pharmaceuticals Corporation | 8 | $164 |
| UCB, Inc. | 5 | $162 |
| Galderma Laboratories, L.P. | 9 | $143 |
| Regeneron Healthcare Solutions, Inc. | 4 | $128 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $64 |
| E.R. Squibb & Sons, L.L.C. | 3 | $63 |
| Organon LLC | 4 | $60 |
| GENZYME CORPORATION | 1 | $30 |
Products named: TREMFYA, RINVOQ, Bimzelx, DUPIXENT, NEMLUVIO, COSENTYX, SKYRIZI, Sotyktu.
Industry payments across CO — which companies pay providers there.
